Go
View All
PPI
Primary acquired melanosis (PAM)
Primary care physician (PCP)
Primary site of esophageal cancer based on proximal edge of tumor
Primary sites of the paranasal sinuses
Primary tumor (T)
Probability of survival according to mutation status
Prognostic scoring index
Prognostic scoring index for gestational trophoblastic tumors
Prognostic tools for prostate cancer that met all AJCC quality criteria
Proposed risk categories for primary soft tissue sarcomas
Prostate cancer
Pseudomyxoma peritonei
pT1 is defined as tumor limited to testis (including rete testis invasion) without lymphovascular invasion
pT2 is defined as tumor limited to testis (including rete testis invasion) with lymphovascular invasion (shown here) or tumor invading hilar soft tissue, epididymis or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion (shown here)
pT2 is defined as tumor limited to testis (including rete testis invasion) with lymphovascular invasion or tumor invading hilar soft tissue (shown here), epididymis (shown here) or penetrating visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion
PTH
PTT
Radiation Therapy Oncology Group (RTOG)
Recommendation for the diagnostic evaluation of children with NHL
Recommendations for the diagnostic evaluation of patients with lymphoma
Rectal carcinoma
Recurrence-free and overall survival for patients treated with 1 versus 3 years of imatinib for higher-risk GIST, defined as having at least one of the following features: (1) longest tumor diameter greater than 10
Recurrent cytogenetic abnormalities in adult ALL and their prognostic significance,,-
Displaying items 781 - 810 of 1114